BCL2 and neoplasm: A decrease in the Ki-67 index at the treatment stages, high expression of Caspase-3, low expression of bcl-2 and p53, low levels of CRP, CEA and SCCA, and HPV-positive tumor status are associated with a favorable prognosis of the course of the tumor process [35].